A nitric oxide producing pin-to-hole spark discharge plasma enhances endothelial cell proliferation and migration

Plasma Medicine

Volumn 1, Issue 3-4, 2011, Pages 279-293

  Arjunan, Krishna Priya ^a   Clyne, Alisa Morss ^a,b  

^a DREXEL UNIVERSITY   (United States)

^b Drexel University   (United States)

Author keywords

Angiogenesis; Nitric oxide; Pin to hole spark discharge; Plasma; Wound healing

Indexed keywords

CELL PROLIFERATION; CELLS; COLLAGEN; CYTOLOGY; ELECTRIC DISCHARGES; MEDICAL APPLICATIONS; NITRIC OXIDE; PLASMA APPLICATIONS; PLASMAS; TELEMETERING; TISSUE;

ANGIOGENESIS; DOSE-DEPENDENT MANNER; MIGRATION DISTANCE; PHOSPHATE-BUFFERED SALINES; SPARK DISCHARGE; UNTREATED CONTROL; VASCULAR FUNCTIONS; WOUND HEALING;

ENDOTHELIAL CELLS;

NITRIC OXIDE; NITRITE; PHOSPHATE BUFFERED SALINE; SODIUM CHLORIDE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOPLASM; ENDOTHELIUM CELL; EVOKED RESPONSE; IN VITRO STUDY; LIQUID; NONHUMAN; PLASMA; PRIORITY JOURNAL; VASCULARIZATION; WOUND HEALING;

EID: 84875143878     PISSN: 19475764     EISSN: 19475772     Source Type: Journal    
DOI: 10.1615/PlasmaMed.2012006389     Document Type: Article

References (55)

1. Kojda G, Harrison D. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res. 1999;43:562-71.
2. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. PNAS. 1987;84(24):9265-9.
3. Witte MB, Barbul A. Role of Nitric Oxide in Wound Repair. Am J Surg. 2002;183:406-12.
4. Pipili-Synetos E, Sakkoula E, Maragoudakis ME. Nitric oxide is involved in the regulation of angiogenesis. Br J Pharmacol. 1993;108(4):855-7.
5. Papapetropoulos A, Cziraki A, Rubin JW, Stone CD, Catravas JD. cGMP Accumulation and gene expression of soluble guanylate cyclase in human vascular tissue. J Cell Physiol. 1996;167(2):213-21.
6. Fukumura D, Kashiwagi S, Jain RK. The role of nitric oxide in tumor progression. Nature Rev Cancer. 2006;6:521-34.
7. Gow AJ, Farkouh CR, Munson DA, Posencheg MA, Ischiropoulos H. Biological significance of nitric oxide-mediated protein modifications. Am J Physiol Lung Cell Mol Physiol. 2004;287(2):262-8.
8. Lander HM, Hajjar DP, Hempsteadi BL, Mirza UA, Chait BT, Campbell S, Quilliam LA. A molecular redox switch on p21ras. Structural basis for the nitric oxide-p21ras interaction. J Biol Chem. 1997;272(7):4323-6.
9. Zaragoza C, Soria E, López E, Browning D, Balbín M, López-Otí C, Lamas S. Activation of the mitogen activated protein kinase extracellular signal-regulated kinase 1 and 2 by the nitric oxide-cGMP-cGMP-dependent protein kinase axis regulates the expression of matrix metalloproteinase 13 in vascular endothelial cells. Molec Pharmacol. 2002;62(4):927-35.
10. Oliveira CJR, Schindler F, Ventura AM, Morais MS, Arai RJ, Debbas V, Stern A, Monteiro HP. Nitric oxide and cGMP activate the Ras-MAP kinase pathway-stimulating protein tyrosine phosphorylation in rabbit aortic endothelial cells. Free Rad Biol Med. 2003;35(4):381-96.
11. Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ, Bicknell R. Nitric oxide synthase lies downstream from vascular endothelial growth factorinduced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest. 1997;99(11):2625-34.
12. Parenti A, Morbidelli L, Ledda F, Granger HJ, Ziche M. The bradykinin/B1 receptor promotes angiogenesis by up-regulation of endogenous FGF-2 in endothelium via the nitric oxide synthase pathway. FASEB. 2001;15(8):1487-9.
13. Ziche M, Parenti A, Ledda F, Dell'Era P, Granger HJ, Maggi CA, Presta M. Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF. Circ Res. 1997;80(6):845-52.
14. Donnini S, Solito R, Giachetti A, Granger HJ, Ziche M, Morbidelli L. Fibroblast growth factor-2 mediates angiotensin-converting enzyme inhibitor-induced angiogenesis in coronary endothelium. J Pharmacol Exper Therapeut. 2006;319(2):515-22.
15. Kasuno K, Takabuchi S, Fukuda K, Kizaka-Kondoh S, Yodoi J, Adachi T, Semenza GL, Hirota, K. Nitric oxide induces hypoxia-inducible factor 1 activation that is dependent on MAPK and phosphatidylinositol 3-kinase signaling. J Biol Chem. 2004;279(4):2550-8.
16. Frostell C, Fratacci M, Wain J, Jones R, Zapol W. Inhaled nitric oxide. a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction [published erratum appears in Circulation 1991 Nov;84(5):2212]. Circulation. 1991;83(6):2038-47.
17. Adrie C, Ichinose F, Holzmann A, Keefer L, Hurford WE, Zapol WM. Pulmonary vasodilation by nitric oxide gas and prodrug aerosols in acute pulmonary hypertension. J Appl Physiol. 1998;84(2):435-41.
18. Griffiths MJD, Evans TW. Inhaled nitric oxide therapy in adults. N Eng J Med. 2005;353:2683-95.
19. Greenough A. Inhaled nitric oxide in the neonatal period. Expert Opin Invest Drugs. 2000;9(7):1601-9.
20. Roberts JD, Fineman JR, Morin FC, Shaul PW, Rimar S, Schreiber MD, Polin RA, Zwass MS, Zayek MM, Gross I, Heymann MA, Zapol W., Thusu KG, Zellers TM, Wylam ME, and Zaslavsky A, for the Inhaled Nitric Oxide Study Group. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. NEJM. 1997;336(9):605-10.
21. Isenberg JS, Ridnour LA, Espey MG, Wink DA, Roberts DD. Nitric oxide in wound healing. Microsurgery. 2005;25(5):442-51.
22. Schaffer MR, Tantry U, Efron PA, Ahrendt GM, Thornton FJ, Barbul A. Diabetesimpaired healing and reduced wound nitric oxide synthesis: a possible pathophysiologic correlation. Surgery. 1997;121:513-9.
23. Witte MB, Kiyama T, Barbul A. Nitric oxide enhances experimental wound healing in diabetes. Br J Surg. 2002;89:1594-601.
24. Li Y, Lee PI. Controlled nitric oxide delivery platform based on S-nitrosothiol conjugated interpolymer complexes for diabetic wound healing. Molec Pharm. 2009;7(1):254-66.
25. Miller MR, Megson IL. Recent development in NO donor drugs. Brit J Pharmacol. 2007;151:305-21.
26. Ignarro LJ. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu ReV Pharmacol Toxicol. 1990;30:535-60.
27. Cai TB, Wang PG, Holder AA. NO and NO donors. In: Nitric oxide donors for pharmaceutical and biological applications. Wang PG, Cai TB, Taniguchi N, eds. Weinheim: Wiley VCH; 2005.
28. Shekhter AB, Kabisov RK, Pekshev AV, Kozlov NP, Perov YL. Experimental and clinical validation of plasmadynamic therapy of wounds with nitric oxide. Bull Exper Biol Med. 1998;126(2):829-34.
29. Shekhter AB, Serezhenkov VA, Rudenko TG, Pekshev AV, Vanin AF. Beneficial effect of gaseous nitric oxide on the healing of skin wounds. nitric oxide-biology and chemistry. 2005;12(4):210-9.
30. Liebmann J, Scherer J, Bibinov N, Rajasekaran P, Kovacs R, Gesche R, Awakowicz P, Kolb-Bachofen V. Biological effects of nitric oxide generated by an atmospheric pressure gas-plasma on human skin cells. Nitric Oxide. 2011;24(1):8-16.
31. Gostev V, editor. Cold plasma in biological investigations. NATO Advanced Study Institute (ASI):Plasma assisted decontamination of biological and chemical agents; 2007; Cesme, Turkey.
32. Gostev V, Dobrynin D, editors. Medical microplasmatron 3rd Int Workshop on Microplasmas 2006; Greifswald, Germany.
33. Misyn F, Besedin E, Gostev V, Komkova O. Experimental studying of bactericidal action of cold plasma. Diagnostics and treatment of infectious diseases; Petrozavodsk, Russia, 2000.
34. Misyn FA, Besedin EV, Obraztsova AM, Gostev VA. Experimental treatment of bacterial ulcerous keratitis with "cold" plasma. Diagnostics and Treatment of Infectious Diseases. Petrozavodsk, Russia, 2000.
35. Misyn FA, Besedin EV, Komkova OP, Gostev VA. Experimental investigation of bactericidal influence of "cold" plasma and its interaction with cornea. Diagnostics and Treatment of Infectious Diseases; Petrozavodsk, Russia, 2000.
36. Misyn FA, Gostev VA. "Cold" Plasma application for curing of eyelid phlegmon Diagnostics and Treatment of Infectious Diseases; Petrozavodsk, Russia, 2000.
37. Dobrynin D, Arjunan K, Fridman A, Friedman G, Clyne AM. Direct and controllable nitric oxide delivery into biological media and living cells by a pin-to-hole spark discharge (PHD) plasma. J Physics D: Appl Physics. 2011;44:075201.
38. Kuhn S, Bibinov N, Gesche R, Awakowicz P. Non-thermal atmospheric pressure HF plasma source: generation of nitric oxide and ozone for bio-medical applications. Plasma Sources Sci Technol. 2010;19:015013.
39. Namihira T, Sakai S, Matsuda M, Wang D, Kiyan T, Akiyama H, Okamoto K, Toda K. Temperature and nitric oxide generation in a pulsed arc discharge plasma. Plasma Sci Technol. 2007;9:747.
40. Pipa AV, Bindemann T, Foest R, Kindel E, Ropcke J, Weltmann K-D. Absolute production rate measurements of nitric oxide by an atmospheric pressure plasma jet (APPJ). J Phys D: Appl Phys. 2008;41:194011.
41. Arjunan KP, Clyne AM. Hydroxyl radical and hydrogen peroxide are primarily responsible for dielectric barrier discharge plasma-induced angiogenesis. Plasma Process Polymers. 2011;8(12):1154-64.
42. Arjunan KP, Friedman G, Fridman A, Clyne AM. Non-thermal dielectric barrier discharge plasma induces angiogenesis through reactive oxygen species. J Royal Soc: Interface. 2012;9(66):147-57.
43. Kalghatgi S, Friedman G, Fridman A, Clyne A. Endothelial cell proliferation is enhanced by low dose non-thermal plasma through fibroblast growth factor-2 release. Ann Biomed Engin. 2010;38(3):748-57.
44. Wong MK, Gotlieb AI. In vitro reendothelialization of a single-cell wound. Role of microfilament bundles in rapid lamellipodia-mediated wound closure. Lab Invest. 1984;51(1):75-81.
45. Chakravarthy K, Dobrynin D, Fridman G, Friedman G, Murthy S, Fridman AA. Cold spark discharge plasma treatment of inflammatory bowel disease in an animal model of ulcerative colitis. Plasma Med J. 2011;1(1):3-19.
46. Kojima H, Nakatsubo N, Kikuchi K, Kawahara S, Kirino Y, Nagoshi H, et al. Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal Chem. 1998(70):2446-53.
47. Maragos CM, Morley D, Wink DA, Dunams TM, Saavedra JE, Hoffman A, Bove AA, Isaac L, Hrabie JA, Keefer LK. Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide: vasorelaxant effects. J Med Chem. 1991(34):3242-7.
48. Dixit P, Hern-Anderson D, Ranieri J, Schmidt CE. Vascular graft endothelialization: comparative analysis of canine and human endothelial cell migration on natural biomaterials. J Biomed Mater Res. 2001;56(4):545-55.
49. Dollé J, Rezvan A, Allen FD, Lazarovici P, Lelkes PI. Nerve growth factor-induced migration of endothelial cells. J Pharmacol Exp Ther. 2005;315(3):1220-7.
50. Bryan NS, Fernandez BO, Bauer SM, Garcia-Saura MF, Milsom AB, Rassaf T, Maloney RE, Bharti A, Rodriguez J, Feelisch M. Nitrite is a signaling molecule and regulator of gene expression in mammalian tissues. Nat Chem Biol. 2005;1(5):290-7.
51. Larsen FJ, Ekblom B, Sahlin K, Lundberg JO, Weitzberg E. Effects of dietary nitrate on blood pressure in healthy volunteers. NEJM. 2006;355(26):2792-3. Epub 2006/12/29.
52. Schwalm S, Pfeilschifter J, Huwiler A. Sphingosine kinase 1 is critically involved in nitric oxide-mediated human endothelial cell migration and tube formation. Brit J Pharmacol. 2010;160(7):1641-51.
53. Genís L, Gonzalo P, Tutor AS, Gálvez BG, Martínez-Ruiz A, Zaragoza C, Lamas S, Tryggvason K, Apte SS, Arroyo AG. Functional interplay between endothelial nitric oxide synthase and membrane type 1-matrix metalloproteinase in migrating endothelial cells. Blood. 2007;110(8):2916-23.
54. Yang M, Yang Y, Zhang S, Kahn AM. Insulin-stimulated hydrogen peroxide increases guanylate cyclase activity in vascular smooth muscle. Hypertension. 2003;42(4):569-73. Epub 2003/09/10.
55. Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E. The antioxidant properties of serum albumin. FEBS Lett. 2008;582(13):1783-7.